Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-04

Clinical Trial Update: Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tibolone to transdermal estradiol/norethindrone acetate on sexual function in naturally postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tibolone (tibolone)
  • Transdermal E2/NETA

Snippet

Sponsor: Organon and Co | Conditions: Sexual Dysfunction | Phase 3 | Status: COMPLETED